Table 1.
Echocardiographic data of left ventricular function four weeks after AngII infusion
| Group | LVEF (%) | LVFS (%) | LVIDd (mm) | LVIDs (mm) | LVESV (mm) | MAPSE (mm) |
|---|---|---|---|---|---|---|
| Control | 74.720±1.102 | 42.410±0.980 | 3.244±0.199 | 1.868±0.122 | 11.030±1.763 | 0.651±0.035 |
| AngII | 49.730±1.635* | 24.790±0.964* | 3.820±0.053* | 2.876±0.072* | 31.780±1.996* | 0.474±0.020* |
| LIPUS | 73.290±1.297 | 41.120±1.141 | 3.116±0.045 | 1.832±0.027 | 10.200±0.370 | 0.653±0.029 |
| AngII+LIPUS | 64.480±1.666# | 33.980±1.224# | 2.959±0.043# | 1.952±0.019# | 11.970±0.290# | 0.615±0.029# |
The results are presented as mean±standard error of the mean (SEM), n>3 per group. * P<0.05 vs. the control group; # P<0.05 vs. the model group. AngII, angiotensin II; LIPUS, low-intensity pulsed ultrasound; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; LVIDd, left ventricular internal diameters at end diastole; LVIDs, left ventricular internal diameters at end systole; LVESV, left ventricle end-systolic volume; MAPSE, mitral annular plane systolic excursion.